In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma.

Adrien KrugAymen SaidaneChiara MartinelloFloriane FusilAlexander MichelsChristian J BuchholzJean-Ehrland RicciEls Verhoeyen

Published in: Journal of experimental & clinical cancer research : CR (2024)

This is the first description of in vivo generated CAR T cells for therapy of a T cell lymphoma. The strategy described offers a new therapeutic concept for patients suffering from CD4-driven T cell lymphomas.

Keyphrases

cell therapy
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
mesenchymal stem cells
peritoneal dialysis
prognostic factors
patient reported outcomes
smoking cessation
replacement therapy
nk cells